Additional European Equity News - 27th October 2026

Assa Abloy (ASSAB SS) - Q3 2026 (SEK): Sales 40.8bln (exp. 40.7bln), EBITA 7.61bln (exp. 7.38bln), EBIT 7.1bln (exp. 6.92bln). (Assa Abloy)

AstraZeneca (AZN LN) - Co.'s Enhertu has been approved in the EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast cancer. (AstraZeneca)

Beiersdorf (BEI GY) - 9M 2026 (EUR): Revenue 7.31bln, -3% Y/Y. Q3 Revenue 2.34bln, 0.4% Y/Y. Confirms FY26 guidance. (Beiersdorf)

Infineon Technologies (IFX GY) - Co. is establishing the world's first high-volume production facility for gallium nitride power semiconductors on 300mm wafers in Europe, investing EUR 1.1bln at its Villach site in Austria to develop a global competence centre for power semiconductors. (Newswires)

Informa (INF LN) - 9M Trading Update: Underlying revenue growth +6.5%. Confirms FY double-digit underlying earnings growth. (Informa)

Reckitt (RKT LN) - Q3 2026 (GBP): Net Revenue 3.36bln (exp. 3.35bln), LFL +3.2%. Cuts its FY26 core LFL net revenue guidance to 3.5-4.5% (prev. guided 4-5%), reflecting the Lysol disruption and category slowdown in China VMS in Q3 and positive demand for seasonal cold & flu brands in early Q4. (Reckitt)

Severn Trent (SVT LN) - Co. announces that Helen Miles is to step down as CFO. (Severn Trent)

Sobi (SOBI SS) - Q3 2026 (SEK): Revenue 9.12bln (exp. 8.95bln). Updates its FY26 guidance, now sees revenue to grow by high-teens to low-20s percent at CER (prev. guided mid-to-high-teens percent). (SOBI)

Vistry (VTY LN) - Co. appoints Helen Miles as CFO, who will join the board during 2027. (Vistry)

Remy Cointreau (RCO FP) downgraded to Market Perform from Outperform at Societe Generale